Access the full text.
Sign up today, get DeepDyve free for 14 days.
GS Hoffman, MC Cid, KE Rendt-Zagar (2007)
Infliximab for maintenance of glucocorticosteroid-induced remission of giant cell arteritis: a randomized trialAnn Intern Med, 146
H. Petri, A. Nevitt, K. Sarsour, P. Napalkov, N. Collinson (2015)
Incidence of Giant Cell Arteritis and Characteristics of Patients: Data‐Driven Analysis of ComorbiditiesArthritis Care & Research, 67
S. Sciascia, D. Rossi, D. Roccatello (2011)
Interleukin 6 Blockade as Steroid-sparing Treatment for 2 Patients with Giant Cell ArteritisThe Journal of Rheumatology, 38
C. Salvarani, L. Cimino, P. Macchioni, D. Consonni, F. Cantini, G. Bajocchi, N. Pipitone, M. Catanoso, L. Boiardi (2005)
Risk factors for visual loss in an Italian population-based cohort of patients with giant cell arteritis.Arthritis and rheumatism, 53 2
G. Nesher, Y. Berkun, M. Mates, M. Baras, R. Nesher, A. Rubinow, M. Sonnenblick (2004)
Risk Factors for Cranial Ischemic Complications in Giant Cell ArteritisMedicine, 83
G. Hoffman, M. Cid, D. Hellmann, L. Guillevin, J. Stone, J. Schousboe, P. Cohen, L. Calabrese, H. Dickler, P. Merkel, P. Fortin, J. Flynn, G. Locker, Kirk Easley, E. Schned, G. Hunder, M. Sneller, C. Tuggle, H. Swanson, J. Hernández-Rodríguez, A. López-Soto, D. Bork, D. Hoffman, K. Kalunian, D. Klashman, W. Wilke, R. Scheetz, B. Mandell, B. Fessler, G. Kosmorsky, R. Prayson, R. Luqmani, G. Nuki, E. Mcrorie, Y. Sherrer, S. Baca, B. Walsh, D. Ferland, M. Soubrier, Hyon Choi, W. Gross, A. Segal, C. Ludivico, X. Puéchal (2002)
A multicenter, randomized, double-blind, placebo-controlled trial of adjuvant methotrexate treatment for giant cell arteritis.Arthritis and rheumatism, 46 5
P. Duhaut, L. Pinède, S. Demolombe-Ragué, R. Loire, D. Seydoux, J. Ninet, J. Pasquier (1998)
Giant cell arteritis and cardiovascular risk factors: a multicenter, prospective case-control study. Groupe de Recherche sur l'Artérite à Cellules Géantes.Arthritis and rheumatism, 41 11
G. Hunder, S. Sheps, G. Allen, J. Joyce (1975)
Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis: comparison in a prospective study.Annals of internal medicine, 82 5
M. González-Gay, T. Vázquez-Rodríguez, M. Lopez-Diaz, J. Miranda-filloy, C. González-Juanatey, Javier Martín, J. Llorca (2009)
Epidemiology of giant cell arteritis and polymyalgia rheumatica.Arthritis and rheumatism, 61 10
E. Liozon, François Herrmann, K. Ly, P. Robert, V. Loustaud, P. Soria, E. Vidal (2001)
Risk factors for visual loss in giant cell (temporal) arteritis: a prospective study of 174 patients.The American journal of medicine, 111 3
G. Myklebust, J. Gran (1996)
A PROSPECTIVE STUDY OF 287 PATIENTS WITH POLYMYALGIA RHEUMATICA AND TEMPORAL ARTERITIS: CLINICAL AND LABORATORY MANIFESTATIONS AT ONSET OF DISEASE AND AT THE TIME OF DIAGNOSISRheumatology, 35
G. Hoffman, M. Cid, Karen Rendt-Zagar, P. Merkel, C. Weyand, J. Stone, C. Salvarani, Weichun Xu, S. Visvanathan, Mahboob Rahman (2007)
Infliximab for Maintenance of Glucocorticosteroid-Induced Remission of Giant Cell ArteritisAnnals of Internal Medicine, 146
C. Beyer, R. Axmann, E. Sahinbegovic, J. Distler, B. Manger, G. Schett, J. Zwerina (2011)
Anti-interleukin 6 receptor therapy as rescue treatment for giant cell arteritisAnnals of the Rheumatic Diseases, 70
R. Seror, G. Baron, E. Hachulla, M. Debandt, C. Larroche, X. Puéchal, F. Maurier, B. Wazières, T. Quéméneur, P. Ravaud, X. Mariette (2013)
Adalimumab for steroid sparing in patients with giant-cell arteritis: results of a multicentre randomised controlled trialAnnals of the Rheumatic Diseases, 73
M. González-Gay, S. Barros, M. Lopez-Diaz, C. García‐Porrúa, A. Sánchez-Andrade, J. Llorca (2005)
Giant Cell Arteritis: Disease Patterns of Clinical Presentation in a Series of 240 PatientsMedicine, 84
Shigeto Kobayashi, T. Yano, Y. Matsumoto, F. Numano, N. Nakajima, K. Yasuda, C. Yutani, T. Nakayama, A. Tamakoshi, T. Kawamura, Y. Ohno, Y. Inaba, H. Hashimoto (2003)
Clinical and epidemiologic analysis of giant cell (temporal) arteritis from a nationwide survey in 1998 in Japan: the first government-supported nationwide survey.Arthritis and rheumatism, 49 4
M. Khalifa, M. Karmani, N. Jaafoura, N. Kaabia, A. Letaief, F. Bahri (2009)
Epidemiological and clinical features of giant cell arteritis in Tunisia.European journal of internal medicine, 20 2
P. Henkind (1976)
Daily and alternate-day corticosteroid regimens in treatment of giant cell arteritis
Michael Lee, Scott Smith, A. Galor, G. Hoffman (2006)
Antiplatelet and anticoagulant therapy in patients with giant cell arteritis.Arthritis and rheumatism, 54 10
C. Mukhtyar, L. Guillevin, M. Cid, B. Dasgupta, K. Groot, W. Gross, T. Hauser, B. Hellmich, D. Jayne, C. Kallenberg, P. Merkel, H. Raspe, C. Salvarani, David Scott, C. Stegeman, R. Watts, K. Westman, J. Witter, H. Yazici, R. Luqmani (2008)
EULAR recommendations for the management of large vessel vasculitisAnnals of the Rheumatic Diseases, 68
G. Mykelbust, J. Gran (1997)
A prospective study of 287 patients with polymyalgia rheumatica and temporal arteritis: clinical and laboratory manifestations at onset of disease and at the time of diagnosis.British journal of rheumatology, 35 11
M. Yates, K. Graham, R. Watts, A. Macgregor (2016)
The prevalence of giant cell arteritis and polymyalgia rheumatica in a UK primary care populationBMC Musculoskeletal Disorders, 17
S. Unizony, L. Arias‐Urdaneta, E. Miloslavsky, S. Arvikar, A. Khosroshahi, B. Keroack, J. Stone, J. Stone (2012)
Tocilizumab for the treatment of large‐vessel vasculitis (giant cell arteritis, Takayasu arteritis) and polymyalgia rheumaticaArthritis Care & Research, 64
A. Myles, T. Perera, M. Ridley (1992)
Prevention of blindness in giant cell arteritis by corticosteroid treatment.British journal of rheumatology, 31 2
A. Skapenko, J. Smolen, A. Kavanaugh, V. Arora, H. Kupper, H. Schulze-Koops (2019)
Genetic markers associated with clinical and radiographic response in adalimumab plus methotrexate-treated rheumatoid arthritis patients in OPTIMA.Clinical and experimental rheumatology
M. González-Gay, T. Pina (2015)
Giant Cell Arteritis and Polymyalgia Rheumatica: an UpdateCurrent Rheumatology Reports, 17
J. Loricera, R. Blanco, J. Hernández, S. Castañeda, A. Mera, E. Perez-Pampin, E. Peiró, A. Humbría, J. Calvo-Alén, E. Aurrecoechea, J. Narváez, A. Sánchez-Andrade, P. Vela, E. Díez, C. Mata, P. Lluch, C. Moll, Í. Hernández, V. Calvo-Río, F. Ortiz-Sanjuan, C. González-Vela, T. Pina, M. González-Gay (2015)
Tocilizumab in giant cell arteritis: Multicenter open-label study of 22 patients.Seminars in arthritis and rheumatism, 44 6
G. Nesher, Y. Berkun, M. Mates, M. Baras, A. Rubinow, M. Sonnenblick (2004)
Low-dose aspirin and prevention of cranial ischemic complications in giant cell arteritis.Arthritis and rheumatism, 50 4
K. Herlyn, Frederike Buckert, W. Gross, E. Reinhold-Keller (2014)
Doubled prevalence rates of ANCA-associated vasculitides and giant cell arteritis between 1994 and 2006 in northern Germany.Rheumatology, 53 5
H. Boysson, J. Boutémy, C. Créveuil, Y. Ollivier, P. Letellier, C. Pagnoux, B. Bienvenu (2013)
Is there a place for cyclophosphamide in the treatment of giant-cell arteritis? A case series and systematic review.Seminars in arthritis and rheumatism, 43 1
C. Dejaco, S. Ramiro, C. Duftner, F. Besson, T. Bley, D. Blockmans, E. Brouwer, M. Cimmino, E. Clark, B. Dasgupta, A. Diamantopoulos, H. Direskeneli, A. Iagnocco, T. Klink, Lorna Neill, C. Ponte, C. Salvarani, R. Slart, M. Whitlock, W. Schmidt (2018)
EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practiceAnnals of the Rheumatic Diseases, 77
E. Dunstan, S. Lester, Maureen Rischmueller, T. Dodd, Rachel Black, Michael Ahern, Leslie Cleland, Peter Roberts‐Thomson, Catherine Hill (2014)
Epidemiology of biopsy‐proven giant cell arteritis in South AustraliaInternal Medicine Journal, 44
V. Martínez-Taboada, V. Rodríguez-valverde, L. Carreño, J. López‐Longo, M. Figueroa, J. Belzunegui, E. Mola, G. Bonilla (2007)
A double-blind placebo controlled trial of etanercept in patients with giant cell arteritis and corticosteroid side effectsAnnals of the Rheumatic Diseases, 67
M. González-Gay, J. Miranda-filloy, M. Lopez-Diaz, R. Pérez-Álvarez, C. González-Juanatey, A. Sánchez-Andrade, Javier Martín, J. Llorca (2007)
Giant Cell Arteritis in Northwestern Spain: A 25-Year Epidemiologic StudyMedicine, 86
Originalien 1 1,3 2 Z Rheumatol 2019 · 78:677–684 Christian von Kiel · Matthias Dreher · Konstantinos Triantafyllias · 4 1,2,3 https://doi.org/10.1007/s00393-018-0484-8 Peter Heinz · Andreas Schwarting Online publiziert: 4. Juni 2018 Schwerpunkt Rheumatologie und klinische Immunologie, Universitätsmedizin der Johannes Gutenberg- © Springer Medizin Verlag GmbH, ein Teil von Universität Mainz, Mainz, Deutschland Springer Nature 2018 ACURA Rheumakliniken Rheinland-Pfalz GmbH, Bad Kreuznach, Deutschland Präventim GmbH, Ober-Olm, Deutschland Redaktion U. Müller-Ladner, Bad Nauheim KV-Rheinland-Pfalz, Mainz, Deutschland U. Lange, Bad Nauheim Versorgungssituation der Riesenzellarteriitis in Rheinland-Pfalz krankungsverhältnis von 3:1 bei Frauen werdenkonnte[1825].Empfehlungenfür Kurze Hinführung zum Thema zu Männern [910]. Khalifa et al. gehen in die Diagnostik und Behandlung der RZA Die Riesenzellarteritis (RZA) ist bei ihrer epidemiologischen Studie von 1986 wurden kürzlich überarbeitet und pu- älteren Patienten eine der häufigsten bis 2003 in Tunesien von einem ausge- bliziert [320]. Glukokortikoide sind die Vaskulitiden. Obwohl in der Literatur glichen Erkrankungsverhältnis bei Mann Initialtherapie der Wahl aufgrund ihrer die möglichen Folgeschäden für die und Frau aus [14]. deutlichenLinderungderSymptomeund Gesundheit beschrieben sind, ist die Die Inzidenz liegt in Abhängigkeit der Beschwerden [20]. Situation der ambulanten Patientenver- Ethnie und Herkunft zwischen 6,9 und Zudem dokumentierten Lee et al. und sorgung nicht ausreichend geklärt. In 29,1
Zeitschrift für Rheumatologie – Springer Journals
Published: Jun 4, 2018
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.